Susquehanna International Group’s 9 Meters Biopharma NMTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-482,100
Closed -$323K 13461
2023
Q2
$323K Sell
482,100
-200
-0% -$177 ﹤0.01% 9284
2023
Q1
$670K Sell
482,300
-29,300
-6% -$55.2K ﹤0.01% 7827
2022
Q4
$645K Buy
511,600
+482,110
+1,635% +$1.1M ﹤0.01% 7216
2022
Q3
$130K Sell
29,490
-2,430
-8% -$12K ﹤0.01% 11431
2022
Q2
$166K Buy
31,920
+11,825
+59% +$111K ﹤0.01% 10902
2022
Q1
$241K Buy
20,095
+4,570
+29% +$62.4K ﹤0.01% 10794
2021
Q4
$304K Sell
15,525
-43,375
-74% -$970K ﹤0.01% 10475
2021
Q3
$1.53M Sell
58,900
-255
-0.4% -$6.01K ﹤0.01% 6425
2021
Q2
$1.3M Sell
59,155
-27,950
-32% -$686K ﹤0.01% 7028
2021
Q1
$2.04M Buy
87,105
+78,720
+939% +$2.42M ﹤0.01% 5866
2020
Q4
$144K Buy
8,385
+285
+4% +$4.75K ﹤0.01% 10274
2020
Q3
$132K Buy
8,100
+5,985
+283% +$72.6K ﹤0.01% 9768
2020
Q2
$24K Buy
+2,115
New +$23.8K ﹤0.01% 9902
2018
Q4
Sell
-735
Closed -$100K 10241
2018
Q3
$100K Sell
735
-1,655
-69% -$284K ﹤0.01% 8605
2018
Q2
$1.13M Buy
+2,390
New +$879K ﹤0.01% 5085

Other funds holding NMTR

Susquehanna International Group's NMTR Position: Q3 2023 in Review

Susquehanna International Group sold out of 9 Meters Biopharma (NMTR) in Q3 2023, closing a stake of 17,089 shares — an estimated $11.5K sold.

Susquehanna International Group first reported a position in NMTR in Q4 2016 and held it in 10 quarters. The position peaked at $1.93M in Q1 2018. 6 funds tracked by Wall St. Rank hold NMTR as of Q3 2023.

  • Susquehanna International Group reported no remaining 9 Meters Biopharma position as of Q3 2023 after selling out during the quarter.
  • Susquehanna International Group sold 17,089 9 Meters Biopharma shares in Q3 2023, an estimated $11.5K.
  • Susquehanna International Group first reported a position in 9 Meters Biopharma in Q4 2016 and held it in 10 quarters.
  • Susquehanna International Group's 9 Meters Biopharma position peaked at $1.93M in Q1 2018.
  • 6 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2023.

Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.